--------------------------------CONTRAINDICATIONS----------------------------- EPCLUSA and ribavirin combination regimen is contraindicated in patients for whom ribavirin is contraindicated (4) HIGHLIGHTS OF PRESCRIBIN

First Page		Document Content
Date: 2016-06-28 12:26:37 Chemistry Gilead Sciences Medicine Clinical medicine Cyclopropanes Breakthrough therapy Combination drugs Organofluorides Sofosbuvir Ledipasvir Simeprevir Velpatasvir/sofosbuvir		--------------------------------CONTRAINDICATIONS----------------------------- EPCLUSA and ribavirin combination regimen is contraindicated in patients for whom ribavirin is contraindicated (4) HIGHLIGHTS OF PRESCRIBIN Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 872,45 KB Share Document on Facebook

	Breakthrough Cancer Therapy DTC DocID: 1sYyU - View Document
	Microsoft Word - GILEAD BRIEFING DocID: 1r2Vm - View Document
	Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio DocID: 1qWZQ - View Document
	24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box DocID: 1qVSm - View Document
	12-AUG:10 CANCER CONTROL ACCRUAL REPORT STUDY O DocID: 1qRuM - View Document